79 related articles for article (PubMed ID: 38590438)
1. Flagellin-modulated inflammasome pathways characterize the human alveolar macrophage response to
Lovelace-Macon L; Baker SM; Ducken D; Seal S; Rerolle G; Tomita D; Smith KD; Schwarz S; West TE
Infect Immun; 2024 May; 92(5):e0006024. PubMed ID: 38619302
[TBL] [Abstract][Full Text] [Related]
2. Function of Burkholderia pseudomallei RpoS and RpoN2 in bacterial invasion, intracellular survival, and multinucleated giant cell formation in mouse macrophage cell line.
Diep DTH; Vong LB; Tungpradabkul S
Antonie Van Leeuwenhoek; 2024 Feb; 117(1):39. PubMed ID: 38388985
[TBL] [Abstract][Full Text] [Related]
3. Innate immune responses of pulmonary epithelial cells to Burkholderia pseudomallei infection.
Sim SH; Liu Y; Wang D; Novem V; Sivalingam SP; Thong TW; Ooi EE; Tan G
PLoS One; 2009 Oct; 4(10):e7308. PubMed ID: 19806192
[TBL] [Abstract][Full Text] [Related]
4. Magnetically modified bacteriophage-triggered ATP release activated EXPAR-CRISPR/Cas14a system for visual detection of Burkholderia pseudomallei.
Yao J; Zhang Z; Pei H; Zhang T; Ruan Y; Liu C; Guo Y; Gu S; Xia Q
Biosens Bioelectron; 2024 Aug; 257():116334. PubMed ID: 38678788
[TBL] [Abstract][Full Text] [Related]
5. Development of Burkholderia mallei and pseudomallei vaccines.
Silva EB; Dow SW
Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
[TBL] [Abstract][Full Text] [Related]
6. The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease?
Lazar Adler NR; Govan B; Cullinane M; Harper M; Adler B; Boyce JD
FEMS Microbiol Rev; 2009 Nov; 33(6):1079-99. PubMed ID: 19732156
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of macrophage infectivity potentiator in
Iwasaki J; Bzdyl NM; Lin-Sullivan DJM; Scheuplein NJ; Dueñas ME; de Jong E; Harmer NJ; Holzgrabe U; Sarkar-Tyson M
Front Cell Infect Microbiol; 2024; 14():1353682. PubMed ID: 38590438
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of TNF-α and IFN-γ expression is a common host immune response in a chronically infected mouse model of melioidosis when comparing multiple human strains of Burkholderia pseudomallei.
Amemiya K; Dankmeyer JL; Bearss JJ; Zeng X; Stonier SW; Soffler C; Cote CK; Welkos SL; Fetterer DP; Chance TB; Trevino SR; Worsham PL; Waag DM
BMC Immunol; 2020 Feb; 21(1):5. PubMed ID: 32013893
[TBL] [Abstract][Full Text] [Related]
9. Activation of Toll-like receptors by Burkholderia pseudomallei.
West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
[TBL] [Abstract][Full Text] [Related]
10. TLR9 Negatively Regulates Intracellular Bacterial Killing by Pyroptosis in Burkholderia pseudomallei
Pudla M; Sanongkiet S; Ekchariyawat P; Luangjindarat C; Ponpuak M; Utaisincharoen P
Microbiol Spectr; 2022 Oct; 10(5):e0348822. PubMed ID: 36194127
[TBL] [Abstract][Full Text] [Related]
11. Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model.
Trevino SR; Dankmeyer JL; Fetterer DP; Klimko CP; Raymond JLW; Moreau AM; Soffler C; Waag DM; Worsham PL; Amemiya K; Ruiz SI; Cote CK; Krakauer T
PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009125. PubMed ID: 33571211
[TBL] [Abstract][Full Text] [Related]
12. Burkholderia pseudomallei-derived miR-3473 enhances NF-κB via targeting TRAF3 and is associated with different inflammatory responses compared to Burkholderia thailandensis in murine macrophages.
Fang Y; Chen H; Hu Y; Li Q; Hu Z; Ma T; Mao X
BMC Microbiol; 2016 Nov; 16(1):283. PubMed ID: 27894256
[TBL] [Abstract][Full Text] [Related]
13. Burkholderia pseudomallei and melioidosis.
Meumann EM; Limmathurotsakul D; Dunachie SJ; Wiersinga WJ; Currie BJ
Nat Rev Microbiol; 2024 Mar; 22(3):155-169. PubMed ID: 37794173
[TBL] [Abstract][Full Text] [Related]
14. Macrophage infectivity potentiator protein, a peptidyl prolyl cis-trans isomerase, essential for Coxiella burnetii growth and pathogenesis.
Debowski AW; Bzdyl NM; Thomas DR; Scott NE; Jenkins CH; Iwasaki J; Kibble EA; Khoo CA; Scheuplein NJ; Seibel PM; Lohr T; Metters G; Bond CS; Norville IH; Stubbs KA; Harmer NJ; Holzgrabe U; Newton HJ; Sarkar-Tyson M
PLoS Pathog; 2023 Jul; 19(7):e1011491. PubMed ID: 37399210
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Structure-Activity Relationships of Novel Inhibitors of the Macrophage Infectivity Potentiator (Mip) Proteins of
Scheuplein NJ; Bzdyl NM; Lohr T; Kibble EA; Hasenkopf A; Herbst C; Sarkar-Tyson M; Holzgrabe U
J Med Chem; 2023 Jul; 66(13):8876-8895. PubMed ID: 37389560
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
